Literature DB >> 15238705

Preparation and immunological studies of protein conjugates of N -acylneuraminic acids.

Peter Chefalo1, Yanbin Pan, Nancy Nagy, Clifford Harding, Zhongwu Guo.   

Abstract

The overexpression of N -acetylneuraminic acid (Neu5Ac) is closely correlated with malignant transformations. Thus, Neu5Ac is an important target in the design of cancer vaccines. To study the influence of chemical modifications of Neu5Ac on its immunological properties, the alpha-allyl glycosides of five differently N -acylated neuraminic acid derivatives were prepared. Following selective ozonolysis of their allyl group to form an aldehyde functionality, they were coupled to keyhole limpet hemocyanin (KLH) via reductive amination. Resultant glycoconjugates were studied in C57BL/6 mice. The N -propionyl, N - iso- butanoyl and N -phenylacetyl derivatives of neuraminic acid provoked robust immune responses of various antibody isotypes, including IgM, IgG1, IgG2a and IgG3, whereas N -trifluoropropionylneuraminic acid and natural Neu5Ac were essentially nonimmunogenic. Moreover, the N -phenylacetyl and N - iso- butanoyl derivatives mainly induced IgG responses that are desirable for antitumor applications. These results raise the promise of formulating effective glycoconjugate cancer vaccines via derivatizing sialic acid residues of sialooligosaccharides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238705      PMCID: PMC3178808          DOI: 10.1023/B:GLYC.0000033997.01760.b9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  27 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Substrate specificity of the sialic acid biosynthetic pathway.

Authors:  C L Jacobs; S Goon; K J Yarema; S Hinderlich; H C Hang; D H Chai; C R Bertozzi
Journal:  Biochemistry       Date:  2001-10-30       Impact factor: 3.162

3.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

Review 4.  Chemical glycobiology.

Authors:  C R Bertozzi; L L Kiessling
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 5.  Sialic acids as ligands in recognition phenomena.

Authors:  A Varki
Journal:  FASEB J       Date:  1997-03       Impact factor: 5.191

6.  Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma.

Authors:  G Ritter; E Boosfeld; R Adluri; M Calves; H F Oettgen; L J Old; P Livingston
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

7.  From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-03       Impact factor: 15.336

8.  GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

Authors:  F Helling; A Shang; M Calves; S Zhang; S Ren; R K Yu; H F Oettgen; P O Livingston
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

Review 9.  Sialic acids as antigenic determinants of complex carbohydrates.

Authors:  R Schauer
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

10.  Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor.

Authors:  C Schmidt; P Stehling; J Schnitzer; W Reutter; R Horstkorte
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  13 in total

1.  Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.

Authors:  Ruben T Almaraz; Udayanath Aich; Hargun S Khanna; Elaine Tan; Rahul Bhattacharya; Shivam Shah; Kevin J Yarema
Journal:  Biotechnol Bioeng       Date:  2011-11-21       Impact factor: 4.530

Review 2.  Advances in the biology and chemistry of sialic acids.

Authors:  Xi Chen; Ajit Varki
Journal:  ACS Chem Biol       Date:  2010-02-19       Impact factor: 5.100

Review 3.  Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

Authors:  Christopher T Saeui; Esteban Urias; Lingshu Liu; Mohit P Mathew; Kevin J Yarema
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

4.  Exploiting metabolic glycoengineering to advance healthcare.

Authors:  Christian Agatemor; Matthew J Buettner; Ryan Ariss; Keerthana Muthiah; Christopher T Saeui; Kevin J Yarema
Journal:  Nat Rev Chem       Date:  2019-09-06       Impact factor: 34.035

5.  Experimental Design Considerations for In Vitro Non-Natural Glycan Display via Metabolic Oligosaccharide Engineering.

Authors:  Elaine Tan; Ruben T Almaraz; Hargun S Khanna; Jian Du; Kevin J Yarema
Journal:  Curr Protoc Chem Biol       Date:  2010-09-01

Review 6.  Carbohydrate engineered cells for regenerative medicine.

Authors:  Jian Du; Kevin J Yarema
Journal:  Adv Drug Deliv Rev       Date:  2010-02-01       Impact factor: 15.470

7.  Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.

Authors:  Yanbin Pan; Peter Chefalo; Nancy Nagy; Clifford Harding; Zhongwu Guo
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

8.  Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.

Authors:  Jian Wu; Zhongwu Guo
Journal:  Bioconjug Chem       Date:  2006 Nov-Dec       Impact factor: 4.774

9.  Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.

Authors:  Peter Chefalo; Yanbin Pan; Nancy Nagy; Zhongwu Guo; Clifford V Harding
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

Review 10.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.